AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 70 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $13,947,000 | +57.5% | 233,067 | -26.1% | 7.82% | +131.1% |
| Q3 2019 | $8,858,000 | -25.8% | 315,331 | 0.0% | 3.38% | -13.6% |
| Q2 2019 | $11,938,000 | -3.0% | 315,331 | 0.0% | 3.92% | +22.2% |
| Q1 2019 | $12,304,000 | +83.0% | 315,331 | 0.0% | 3.20% | +45.1% |
| Q4 2018 | $6,723,000 | -46.1% | 315,331 | 0.0% | 2.21% | -19.9% |
| Q3 2018 | $12,484,000 | +3.6% | 315,331 | 0.0% | 2.76% | +6.2% |
| Q2 2018 | $12,049,000 | +27.2% | 315,331 | 0.0% | 2.60% | +25.7% |
| Q1 2018 | $9,476,000 | +735.6% | 315,331 | +373.8% | 2.06% | +374.7% |
| Q1 2017 | $1,134,000 | -6.7% | 66,553 | 0.0% | 0.44% | -17.6% |
| Q4 2016 | $1,216,000 | +2.6% | 66,553 | 0.0% | 0.53% | -4.7% |
| Q3 2016 | $1,185,000 | – | 66,553 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |